| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $416.4K | - | |
| CFO | 26.0K | $180.4K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - | |
| Dir | 7.0K | $48.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2015 | Madero Miguel | Director | Sale+OE | 40,386 | $30.49 | $1,231,369.14 | -42.1% | |
| Nov 30, 2015 | Yu K Peony | VP, Clinical Development | Sell | 5,000 | $30.00 | $150,000.00 | -1.4% | |
| Nov 25, 2015 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 5,000 | $30.00 | $150,000.00 | -4.4% | |
| Nov 24, 2015 | Kearns Thomas F Jr | Director | Sell | 7,800 | $28.51 | $222,389.00 | -1.5% | |
| Nov 24, 2015 | Neff Thomas B | Chief Executive Officer | Sell | 27,000 | $28.49 | $769,125.00 | -0.2% | |
| Nov 17, 2015 | Yu K Peony | VP, Clinical Development | Sell | 5,000 | $28.00 | $140,000.00 | -2.7% |